Stereotaxis Inc STXS

Morningstar Rating
$1.70 −0.04 (2.30%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

STXS is trading at a LOCK|%K##P premium.
Price
$1.70
Fair Value
LOCK|FMzSDG
Uncertainty
LOCK|v$
1-Star Price
LOCK|#JCR%$B
5-Star Price
LOCK|$@%xvh
Economic Moat
LOCK|ch
Capital Allocation

News

Trading Information

Previous Close Price
$1.74
Day Range
$1.641.75
52-Week Range
$1.593.59
Bid/Ask
$1.66 / $1.72
Shares Outstanding
99.43M
Market Cap
$166.15M
Volume/Avg
567,808 / 471,247

Key Statistics

Price/Earnings (Normalized)
Price/Sales
5.47
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
131

Competitors

Valuation

Metric
STXS
ISRG
Price/Earnings (Normalized)
44.42
Price/Book Value
12.368.67
Price/Sales
5.4714.60
Price/Cash Flow
31.92
Price/Earnings
STXS
ISRG

Financial Strength

Metric
STXS
ISRG
Quick Ratio
1.053.26
Current Ratio
1.564.61
Interest Coverage
Quick Ratio
STXS
ISRG

Profitability

Metric
STXS
ISRG
Return on Assets (Normalized)
−25.66%17.52%
Return on Equity (Normalized)
−159.39%19.96%
Return on Invested Capital (Normalized)
−68.73%18.11%
Return on Assets
STXS
ISRG

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|pwpwZxTLOCK|lsK$144B
Becton Dickinson & Co
BDX
LOCK|LxLOCK|Scn#!$42B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|D^DZY%LOCK|w>$b$35B
Alcon Inc
ALC
LOCK|X$C$>mLOCK|N@<nw$33B
ResMed Inc
RMD
LOCK|jmCYSpSdLOCK|g?$#$30B
West Pharmaceutical Services Inc
WST
LOCK|F@#Lqh&@LOCK|W<$25B
The Cooper Companies Inc
COO
LOCK|#pKG%TLOCK|$y!W$14B
Solventum Corp
SOLV
LOCK|r#>Xb&LOCK|Ls$13B
Align Technology Inc
ALGN
LOCK|C^zqrZkLOCK|$pGS$13B
Baxter International Inc
BAX
LOCK|$<VLOCK|gq>%%$12B

Sponsor Center